Novartis Ag (NVS) EBT Margin (QoQ) (2009 - 2023)

Novartis Ag (NVS) EBT Margin (QoQ) (2009 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2023 -13,680.00
Mar 31, 2023 -169,454.00
Dec 31, 2022 160,769.00
Sep 30, 2022 23,106.00
Jun 30, 2022 -21,554.00
Mar 31, 2022 20,804.00
Dec 31, 2021 -26,059.00
Sep 30, 2021 25,701.00
Jun 30, 2021 -15,586.00
Mar 31, 2021 -184,559.00
Dec 31, 2020 177,473.00
Sep 30, 2020 23,362.00
Jun 30, 2020 -6,101.00
Jun 30, 2019 -18,995.00
Mar 31, 2019 -38.00
Dec 31, 2018 -1,748.00
Sep 30, 2018 16,773.00
Jun 30, 2018 -23,329.00
Mar 31, 2018 4,179.00
Dec 31, 2017 -5,177.00